Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: South Korea Clear all

535 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20035
20047
20054
200613
200719
200830
200938
201041
201120
201220
201326
201424
201526
201624
201717
201824
201915
202027
202121
202224
202330
202434
202519
202625

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed391
Unknown status56
Recruiting43
Terminated20
Active, not recruiting12
Not yet recruiting8
Enrolling by invitation3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical50
Novo Nordisk A/S47
AstraZeneca43
Eli Lilly and Company29
Boehringer Ingelheim27
Sanofi24
Seoul National University Bundang Hospital20
Daewoong Pharmaceutical Co. LTD.17
Handok Inc.14
Seoul National University Hospital13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2535
Diabetes Mellitus85
Obesity19
Dyslipidemias13
Hypertension13
Overweight13
Hyperglycemia12
Atherosclerosis10
Renal Insufficiency, Chronic10
Cardiovascular Diseases9

Trials

Showing 1 to 25 of 535. Each trial links to its page on Pharma Observatory.

435 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.